Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 31, Number 3—March 2025
Research Letter

Multidrug-Resistant Mycobacterium tuberculosis in a Community Hospital, Luanda, Angola

Ngiambudulu M. Francisco, Alberto Gaviraghi, Francesca Alladio, Ralph Huits, Bruna Carnielli, Elena Salvador, Giacomo Stroffolini, Niccolò Ronzoni, Paolo Cattaneo, Concetta Castilletti, Alberto Kalume, Cristina Mazzi, Alberto Matteelli, Dora Buonfrate, and Federico G. GobbiComments to Author 
Author affiliation: Instituto Nacional de Investigação em Sáude, Luanda, Angola (N.M. Francisco); IRCCS Ospedale Sacro Cuore Don Calabria, Negrar, Italy (A. Gaviraghi, F. Alladio, E. Salvador, G. Stroffolini, N. Ronzoni, P. Cattaneo, C. Castilletti, C. Mazzi, D. Buonfrate, F.G. Gobbi); IRCCS Sacro Cuore Don Calabria Hospital, Verona, Italy (R. Huits); Presidio Ospedale Santa Maria del Prato, Feltre, Italy (B. Carnielli); Hospital Divina Providencia, Luanda (A. Kalume); University of Brescia and Brescia Spedali Civili General Hospital WHO Collaborating Centre for TB/HIV and TB Elimination, Brescia, Italy (A. Matteelli); University of Brescia, Brescia (F.G. Gobbi)

Main Article

Table 1

Resistance profiles of cases in study of multidrug-resistant tuberculosis, Luanda, Angola

Drug No. (%) cases showing resistance, N = 474
Rifampin 38 (8.0)
Isoniazid 19 (4.0)
Fluoroquinolones 2 (0.4)
Amikacin 0
Ethionamide 4 (0.8)

Main Article

Page created: February 04, 2025
Page updated: March 04, 2025
Page reviewed: March 04, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external